KPIs & Operating Metrics(New)

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Cost of Revenue EBIAT Gross Profit Long-Term Debt Issuances Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Preferred Shares Issued Receivables - Net Shares Issued Shares Outstanding Shares Outstanding

Oscar Health (OSCR) Long-Term Debt Repayments (2021)

Oscar Health's Long-Term Debt Repayments history spans 1 years, with the latest figure at -$27000.0 for Q2 2021.

For Q2 2021, Long-Term Debt Repayments changed N/A year-over-year to -$27000.0; the TTM value through Mar 2022 reached -$27000.0, down 100.02%, while the annual FY2021 figure was $153.2 million, N/A changed from the prior year.
Long-Term Debt Repayments reached -$27000.0 in Q2 2021 per OSCR's latest filing, down from $153.2 million in the prior quarter.
In the past five years, Long-Term Debt Repayments ranged from a high of $153.2 million in Q1 2021 to a low of -$27000.0 in Q2 2021.